Back to Search
Start Over
Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase
- Source :
- Haematologica, Vol 109, Iss 4 (2023)
- Publication Year :
- 2023
- Publisher :
- Ferrata Storti Foundation, 2023.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 03906078 and 15928721
- Volume :
- 109
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Haematologica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.1bb003d3eb94499faafb19a07880a180
- Document Type :
- article
- Full Text :
- https://doi.org/10.3324/haematol.2023.283864